Instrument NameOncolytics BioInstrument Symbol(ONC-T)

Instrument ExchangeTSX

USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As many biotech companies within the oncology space begin to roll out their end-of-quarter results, the...

/CNW/ -- USA News Group News Commentary – As many biotech companies within the oncology space begin to roll out their end-of-quarter results, the American...

Today announced third quarter financial results and operational highlights. Highlights include BRACELET-1 ...

Announced third-quarter net loss for the third quarter of 2024 was $9.5 million, compared to a net loss ...

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced third...

Announced it will host a conference call and webcast on Tuesday, November 12, 2024, at 8:30 a.m. ET ...

Will host a conference call and webcast on Tuesday, November 12, at 8:30 a.m. ET to discuss a corporate ...

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that...

Conference call and webcast to take place on Tuesday, November 12, 2024 , at 8:30 a.m. ET

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Each October, breast cancer awareness gains momentum through impactful campaigns and advancements in treatment. However, this October...

/CNW/ -- With every October, breast cancer awareness surges thanks to very effective campaigns and new developments in breast cancer treatment. However, this...

Is issuing a corporate update to provide investors with a deeper understanding of recent data and what ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Although death rates for some cancers are declining, the world is facing a sharp increase in cancer cases among people under 50. Globally,...

/CNW/ -- USA News Group News Commentary – While some forms of cancer are seeing death rates fall, the world is witnessing a global surge in cancers among...

Today issued a corporate update to provide investors with a deeper understanding of recent data and ...

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, is issuing a...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – With the recent wrapping up of the World Cancer Congress 2024 in...

/CNW/ -- USA News Group – Optimism is on the rise in fight against cancer, as researchers are making progress across the field of oncology. Helping to spur on...

/CNW/ -- USA News Group – Cancer rates are rising globally, and the outlook is particularly concerning for men. A recent global study projects an 84% increase...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – The surge in global cancer cases is raising...

/CNW/ -- USA News Group – In the oncology world, there's been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years. However,...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – In the oncology world, there’s been plenty to celebrate...

Announced positive clinical results from BRACELET-1, its randomized Phase 2 study evaluating pelareorep ...

Overall survival (OS) results from BRACELET-1 corroborate results of previous randomized IND-213 breast cancer study Together, these two studies support the...